4.7 Article

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization

Journal

GENOME MEDICINE
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13073-022-01117-8

Keywords

Polygenic risk scores; Report design; Preventative medicine; Personalized medicine; Qualitative semi-structured interviews

Funding

  1. NHGRI [U01HG008685]

Ask authors/readers for more resources

This study investigates the responses of patients and primary care providers (PCPs) to different designs of polygenic risk scores (PRS) clinical reports. The findings suggest that both patients and PCPs prefer the continuous representation of PRS and offer recommendations for report design. PCPs see PRS information as a natural extension of their current practice, but the lack of evidence for clinical utility is a major challenge for PRS implementation.
Background Polygenic risk scores (PRS), which offer information about genomic risk for common diseases, have been proposed for clinical implementation. The ways in which PRS information may influence a patient's health trajectory depend on how both the patient and their primary care provider (PCP) interpret and act on PRS information. We aimed to probe patient and PCP responses to PRS clinical reporting choices Methods Qualitative semi-structured interviews of both patients (N=25) and PCPs (N=21) exploring responses to mock PRS clinical reports of two different designs: binary and continuous representations of PRS. Results Many patients did not understand the numbers representing risk, with high numeracy patients being the exception. However, all the patients still understood a key takeaway that they should ask their PCP about actions to lower their disease risk. PCPs described a diverse range of heuristics they would use to interpret and act on PRS information. Three separate use cases for PRS emerged: to aid in gray-area clinical decision-making, to encourage patients to do what PCPs think patients should be doing anyway (such as exercising regularly), and to identify previously unrecognized high-risk patients. PCPs indicated that receiving below average risk information could be both beneficial and potentially harmful, depending on the use case. For increased risk patients, PCPs were favorable towards integrating PRS information into their practice, though some would only act in the presence of evidence-based guidelines. PCPs describe the report as more than a way to convey information, viewing it as something to structure the whole interaction with the patient. Both patients and PCPs preferred the continuous over the binary representation of PRS (23/25 and 17/21, respectively). We offer recommendations for the developers of PRS to consider for PRS clinical report design in the light of these patient and PCP viewpoints. Conclusions PCPs saw PRS information as a natural extension of their current practice. The most pressing gap for PRS implementation is evidence for clinical utility. Careful clinical report design can help ensure that benefits are realized and harms are minimized.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available